Ultrasound-guided Percutaneous Neuromodulation of the Accessory Nerve in Patients With Whiplash Injury
Effectiveness of Ultrasound-guided Percutaneous Neuromodulation on the Accessory Nerve for Improving the Degree of Neck Disability in Patients With Whiplash Injury: a Randomised Clinical Trial
1 other identifier
interventional
44
1 country
1
Brief Summary
This study evaluates the improvement of patients with whiplash injury by comparing two statistical groups: a control group with exercise alone and an experimental group with exercise and percutaneous musculoskeletal neuromodulation of the accessory nerve. The following variables are evaluated: Neck Disability Index, VAS, cervical ROM, and algometry in the upper trapezius.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedFirst Submitted
Initial submission to the registry
March 10, 2026
CompletedFirst Posted
Study publicly available on registry
May 11, 2026
CompletedMay 11, 2026
May 1, 2026
6 months
March 10, 2026
May 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neck Disability Index (NDI)
It is a scale that measures neck disability in patients with non-specific neck pain. The scale include 10 questions of 6 items with a score from 0 to 5. 0 means no limitation and 5 great limitation. The scores are added up and through indirect proportionality a percentage is obtained, with 0% being absence of pain and disability and 100% being maximum pain and disability.
From enrollment to the end of the treatment at 4 weeks
Secondary Outcomes (3)
Pain threshold in the ascending fibres of the trapezius muscle
From enrollment to the end of treatment at 4 weeks
Active cervical range of motion (ROM)
From enrollment to the end of treatment at 4 weeks
Pain intensity measured using VAS
From enrollment to the end of treatment at 4 weeks
Study Arms (2)
Control Group: Only exercise
ACTIVE COMPARATORThis arm just do exercise, controlled by a phisiotherapist, This group had 13 different exercises.
Experimental Groups: US-PNM + exercise
EXPERIMENTALThis arm had to do exercises and have 1 session per week of a ultrasounded percutaneous neuromodulation.
Interventions
The intervention were 13 different exercises. Of the 13 exercises, 6 are specific activation and strength exercises targeting the deep neck muscles, whilst 7 are general neck strength and endurance exercises. The total duration of the programme will be 40 minutes. Following the first session of the exercise programme, a further session was scheduled for later in the week.
This procedure involved inserting a needle into contact with the epineurium of the accessory nerve at neck level and applying electrical stimulation. With the aid of an ultrasound scanner, the physiotherapist performing the procedures approached the epineurium of the accessory nerve using a solid needle (Agupunt® brand, 0.30 mm × 0.40 mm). Stimulation was performed using a compensated biphasic low-frequency current with a frequency of 2 Hz and a pulse width of 250 microseconds for 20 minutes using the FisioInvasiva® 2.0 device (PRIM, Madrid, Spain) via PES (Percutaneal Electrical Stimulation) currents and an electrode to complete the circuit. The procedure is called Ultrasounded Percutaneous Neuromodulation (US-PNM).
Eligibility Criteria
You may qualify if:
- Having suffered a traffic accident within a period not exceeding two weeks prior to the assessment.
- Diagnosed with Grade I or II Whiplash Associated Disorder (WAD) according to the Quebec Task Force (QTF).
- Being at least 18 years of age.
- Have a Visual Analogue Scale (VAS) score greater than 20 mm.
- Have a cervical disability greater than 10 points according to the NDI.
You may not qualify if:
- Neck pain resulting from previous traffic accidents
- Conditions that may interfere with full participation (cardiovascular and neurological diseases and severe mental disorders)
- Treatment prior to starting the study
- Cervical surgery and congenital spinal disorders
- Fractures and dislocations of the neck vertebrae
- Alcohol or drug abuse
- Allergies to metals
- Belonephobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CEU San Pablo
Logroño, La Rioja, 26003, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator, student of Master
Study Record Dates
First Submitted
March 10, 2026
First Posted
May 11, 2026
Study Start
June 14, 2025
Primary Completion
November 30, 2025
Study Completion
November 30, 2025
Last Updated
May 11, 2026
Record last verified: 2026-05